+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Nutrition - Global Strategic Business Report

  • PDF Icon

    Report

  • 352 Pages
  • February 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4845831
The global market for Oncology Nutrition was valued at US$1.5 Billion in 2024 and is projected to reach US$2.5 Billion by 2030, growing at a CAGR of 9.6% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Oncology Nutrition Market - Key Trends & Drivers Summarized

What Is Oncology Nutrition and Why Is It Critical?

Oncology nutrition focuses on meeting the unique dietary needs of cancer patients to help manage symptoms and improve treatment outcomes. Nutrition plays a pivotal role in oncology because cancer and its treatments can significantly affect the patient's ability to eat and absorb nutrients. Proper nutritional care can help maintain body strength, decrease infection risks, improve quality of life, and enhance recovery rates. It involves personalized diet plans that address specific nutritional deficiencies, manage treatment side effects like nausea and weight loss, and support the body’s immune system and overall health during and after treatment.

How Does Research Influence Oncology Nutrition Practices?

Continuous research in oncology nutrition has deepened understanding of how certain foods and nutrients affect tumor growth, patient resilience, and treatment response. Studies have identified specific nutritional strategies that can mitigate the side effects of cancer treatments, such as chemotherapy-induced nausea or radiation-induced weight loss. For instance, omega-3 fatty acids are found to help preserve muscle mass in cancer patients, while antioxidants in fruits and vegetables may reduce the oxidative stress caused by chemotherapy. This growing body of research supports the development of more effective, evidence-based nutritional guidelines and interventions for cancer care.

What Role Do Healthcare Professionals Play in Oncology Nutrition?

Healthcare professionals, including oncologists, dietitians, and nutrition specialists, play a crucial role in integrating nutrition into cancer care. They work collaboratively to assess the nutritional status of patients, devise customized nutrition plans, and adjust these plans as treatment progresses. Education provided by these professionals is vital, as it empowers patients and caregivers to make informed decisions about food choices and dietary habits during cancer treatment. Their expertise ensures that nutritional strategies are safely and effectively aligned with therapeutic goals, thereby optimizing patient outcomes and adherence to nutrition recommendations.

What Drives the Growth in the Oncology Nutrition Market?

The growth in the oncology nutrition market is driven by several factors, including rising global cancer incidence rates, growing awareness of the link between nutrition and cancer recovery, and advancements in nutritional research. As the global population ages, the number of cancer cases continues to climb, increasing the demand for specialized nutritional strategies to support oncology patients. Moreover, as patients and healthcare providers become more aware of how diet impacts treatment efficacy and patient quality of life, there is a greater emphasis on integrating tailored nutritional care into overall cancer treatment plans. Technological advancements in nutritional assessment tools and increased investment in nutrition-focused research further fuel market growth, enhancing the understanding and implementation of effective oncology nutrition practices.

Scope of the Study

The report analyzes the Oncology Nutrition market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments:

Cancer Type (Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver, Other Cancer Types); End-Use (Hospitals, Home Care, Other End-Uses).

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Head & Neck Cancer Nutrition segment, which is expected to reach US$609.6 Million by 2030 with a CAGR of a 8.5%. The Stomach & Gastrointestinal Cancer Nutrition segment is also set to grow at 11.7% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $521.9 Million in 2024, and China, forecasted to grow at an impressive 11.5% CAGR to reach $254.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Abbott Laboratories, Inc., B. Braun Melsungen AG, Koninklijke DSM N.V., Baxter International, Inc., Fresenius Kabi AG and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Oncology Nutrition Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Oncology Nutrition Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Oncology Nutrition Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Some of the 31 major companies featured in this Oncology Nutrition market report include:

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Koninklijke DSM N.V.
  • Baxter International, Inc.
  • Fresenius Kabi AG
  • Fresenius SE & Co. KGaA
  • Aceto Corporation
  • Meiji Holdings Co., Ltd.
  • Nestle Health Science SA
  • Mead Johnson & Company, LLC.
  • Nutricia BV
  • Alniche Life Sciences Pvt., Ltd.
  • Global Health Products, Inc.
  • Pristine Organics Pvt. Ltd.
  • Hexagon Nutrition

Table of Contents

I. METHODOLOGYMII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Oncology Nutrition - Global Key Competitors Percentage Market Share in 2024 (E)
  • Global Economic Update
  • Cancer - Food choices, Dietary habits and Cancer risk
  • Significance of Proper Nutrition for Cancer Patients
  • What to Eat in Cancer
  • Importance of Adequate Nutrition during Cancer Treatment
  • Nutrition During Cancer Treatment
  • Common Causes of Nutrition and Malnutrition in Cancer Patients
  • Cancer Treatment Side Effects that are Likely to Cause Dehydration and Malnutrition
  • Commercial Feeding Formulas
  • Factors to be Considered When Selecting a Particular Formula
  • Global Market Analysis and Prospects
  • Global Oncology Nutrition Market Witnesses Rapid Growth
  • Developed Regions Account for Major Share, Developing Regions Witness Rapid Growth
  • Competition
  • Recent Market Activity
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Global Incidence of Cancer Drives the Oncology Nutrition Market
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Rising Number of Malnourished Cancer Patients Drive the Demand for Oncology Nutrition Market
  • Patient Diagnosis with Malnutrition
  • Post Treatment Duration and Nutrition for Advanced Cancer
  • Meeting Nutritional Needs of Cancer Patients
  • Nutrition for Breast Cancer Survivorship
  • Introduction of Nutrient-Rich Oncology Nutritional Supplements Ensure Quick Recovery for Cancer Patients
  • Ongoing Research and Development Initiatives Fuel Demand for Oncology Nutrition Products
  • Demand for Gluten and Lactose-Free Enteral Nutrition Formulas Exhibits an Upward Momentum
  • Launch of New Nutritional Products for Cancer Patients
  • Diet for Colon Cancer Surgery
  • Ageing Demographics to Drive Market Demand
  • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
  • Uptrend in Healthcare Spending Drives Market Demand
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
  • Enteral Nutrition Market to Remain Buoyant and Strong
  • Oncology Applications Leads EN Market
  • Shift towards Home Care Boosts Demand for Clinical Nutrition Products
  • Changing Health and Social Care Factors Favor Home Enteral Feeding
  • Increasing Popularity of Intravenous Vitamin C for Cancer Treatment
  • Shift towards Enteral Nutrition Therapies - A Threat to Parenteral Nutrition Market
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Head & Neck by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Head & Neck by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Head & Neck by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Stomach & Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Stomach & Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Stomach & Gastrointestinal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Pancreatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Pancreatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Pancreatic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Breast by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 24: World 15-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 27: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 28: World Oncology Nutrition Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Oncology Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
CANADA
JAPAN
  • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
CHINA
  • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
EUROPE
  • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
FRANCE
  • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
GERMANY
  • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
ITALY
UNITED KINGDOM
  • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
AUSTRALIA
  • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Koninklijke DSM N.V.
  • Baxter International, Inc.
  • Fresenius Kabi AG
  • Fresenius SE & Co. KGaA
  • Aceto Corporation
  • Meiji Holdings Co., Ltd.
  • Nestle Health Science SA
  • Mead Johnson & Company, LLC.
  • Nutricia BV
  • Alniche Life Sciences Pvt., Ltd.
  • Global Health Products, Inc.
  • Pristine Organics Pvt. Ltd.
  • Hexagon Nutrition